Participate in the innovations of tomorrow by funding today’s research.

To donate or leave a legacy to the Cancéropôle CLARA is to contribute in a concrete manner to the fight against cancer. Through your action, you support promising research works, for therapeutic advances that will directly benefits patients.

Prof. Véronique Trillet-Lenoir, Head of medical oncology department, South Lyon Hospital Center, President of Cancéropôle CLARA’s Steering Committee

Why choose to support the Cancéropôle Lyon Auvergne-Rhône-Alpes?

A foundation recognized as a public utility*, the Cancéropôle CLARA’s mission is to boost cancer research through various support programs aimed at 3.200 researchers and cancerology professionals in the Auvergne-Rhône-Alpes region.

We support innovative regional projects, from laboratory research to patients’ bedside, including the industrialization of discoveries to facilitate access to therapeutic innovation. By donating or leaving a legacy to the Cancéropôle, it is your turn to support innovation and regional research in order for patients to benefit from more performing and personalized treatments.

For the past 15 years, the Cancéropôle CLARA has supported over 200 research projects in collaboration with regional research and health centers and the industry sector, thanks to the financing of the French National Cancer Institute, local authorities and other partners. This collective investment represents an amount of €186M for the benefit of innovative solutions in the fight against cancer.



*Under the aegis of the Léa & Napoléon Bullukian Foundation, the Cancéropôle CLARA receives tax benefits related to foundations recognized as a public utility (RUP) such as stipulated by law #87-571 dated July 23, 1987.

Partager cette page

Haut de page